¹⁸F-2-Fluoro-2-Deoxy-<scp>d</scp>-Glucose Positron Emission Tomography in Staging of Locally Advanced Breast Cancer

Abstract

The addition of FDG PET to the standard work-up of patients with LABC may lead to the detection of unexpected distant metastases. This may contribute to a more realistic stratification between patients with true stage III breast cancer and those who are in fact suffering from stage IV disease. Abnormal PET findings should be confirmed to prevent patients from being denied appropriate treatment.